Beijing Science Sun Pharmaceutical Co., Ltd.
SZSE:300485.SZ
11.09 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 120.164 | 226.211 | 161.543 | 672.532 | 789.119 | 573.089 | 1,474.818 | 1,039.147 | 999.404 | 482.127 | 325.078 | 175.316 | 126.939 |
| Short Term Investments
| 1,053.416 | 895.387 | 1,134.589 | 507.688 | 489.343 | -2.659 | -2.016 | 505 | 575 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 1,173.58 | 1,121.597 | 1,296.132 | 1,180.22 | 1,278.462 | 573.089 | 1,474.818 | 1,039.147 | 999.404 | 482.127 | 325.078 | 175.316 | 126.939 |
| Net Receivables
| 59.038 | 91.063 | 99.43 | 129.17 | 174.718 | 251.557 | 80.063 | 14.156 | 0 | 12.971 | 6.373 | 4.094 | 0 |
| Inventory
| 107.062 | 89.092 | 123.055 | 158.64 | 170.165 | 173.53 | 142.198 | 75.08 | 61.124 | 45.994 | 24.639 | 39.052 | 29.873 |
| Other Current Assets
| 13.386 | 24.99 | 14.816 | 15.473 | 17.74 | 263.387 | 25.134 | 541.503 | 575.38 | 19.576 | 16.818 | 9.158 | 22.357 |
| Total Current Assets
| 1,353.067 | 1,320.441 | 1,530.194 | 1,483.503 | 1,630.803 | 1,794.476 | 1,722.212 | 1,655.675 | 1,657.136 | 550.799 | 364.581 | 227.62 | 179.17 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 533.883 | 572.179 | 598.898 | 619.699 | 564.013 | 459.114 | 323.683 | 218.083 | 108.898 | 108.311 | 115.909 | 104.442 | 83.828 |
| Goodwill
| 21.865 | 21.865 | 21.865 | 21.865 | 21.865 | 21.865 | 1.643 | 1.643 | 1.643 | 1.643 | 1.643 | 1.643 | 1.643 |
| Intangible Assets
| 258.922 | 237.853 | 216.97 | 207.084 | 195.559 | 193.24 | 137.094 | 127.544 | 67.601 | 56.839 | 58.476 | 61.134 | 14.898 |
| Goodwill and Intangible Assets
| 280.787 | 259.718 | 238.835 | 228.949 | 217.424 | 215.105 | 138.737 | 129.187 | 69.244 | 58.482 | 60.119 | 62.777 | 16.541 |
| Long Term Investments
| 381.301 | 503.904 | -122.425 | 127.545 | -103.498 | 264.685 | 232.672 | 212.111 | 106.489 | 0 | -0.432 | 0 | 0 |
| Tax Assets
| 2.424 | 5.33 | 2.519 | 2.775 | 1.573 | 2.421 | 0.96 | 0.571 | 0.707 | 0.756 | 0.432 | 0.292 | 0.229 |
| Other Non-Current Assets
| 1,070.74 | 907.511 | 1,153.629 | 528.592 | 495.188 | 24.759 | 35.139 | 0.961 | 2.337 | 0 | 0.432 | 0 | 0 |
| Total Non-Current Assets
| 2,269.135 | 2,248.642 | 1,871.456 | 1,507.559 | 1,174.7 | 966.084 | 731.192 | 560.913 | 287.675 | 167.549 | 176.459 | 167.51 | 100.598 |
| Total Assets
| 3,622.202 | 3,569.083 | 3,401.649 | 2,991.063 | 2,805.503 | 2,760.559 | 2,453.403 | 2,216.588 | 1,944.81 | 718.348 | 541.04 | 395.13 | 279.768 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 15.131 | 21.607 | 27.424 | 28.245 | 24.336 | 44.611 | 77.604 | 66.667 | 12.771 | 8.532 | 7.833 | 5.533 | 5.472 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 16.897 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 1.343 | 3.271 | 7.166 | 8.774 | 7.512 | 40.385 | 13.87 | 10.687 | 9.565 | 9.796 | 10.808 | 3.737 | 9.694 |
| Deferred Revenue
| 0 | 9.123 | 12.571 | 11.103 | 8.465 | 7.746 | 12.962 | 24.678 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 34.974 | 50.058 | 53.872 | 98.686 | 30.851 | 110.944 | 42.164 | 40.528 | 38.445 | 51.693 | 28.69 | 25.905 | 17.227 |
| Total Current Liabilities
| 51.448 | 74.936 | 88.461 | 135.705 | 88.062 | 195.94 | 133.638 | 117.883 | 60.781 | 70.022 | 47.33 | 35.175 | 32.393 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0.275 | 0.745 | 1.216 | 1.686 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 103.162 | 82.159 | 30.082 | 5.424 | 6.194 | 9.134 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 103.162 | 82.159 | 30.082 | 5.424 | 6.194 | 9.134 | 0.275 | 0.745 | 1.216 | 1.686 | 0 | 0 | 0 |
| Total Liabilities
| 154.61 | 157.095 | 118.544 | 141.128 | 94.256 | 205.074 | 133.912 | 118.628 | 61.997 | 71.708 | 47.33 | 35.175 | 32.393 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 481.666 | 481.666 | 481.666 | 481.666 | 484.166 | 484.166 | 240 | 240 | 120 | 90 | 90 | 90 | 90 |
| Retained Earnings
| 1,862.821 | 1,801.298 | 1,699.168 | 1,311.492 | 1,202.513 | 1,130.167 | 933.476 | 740.143 | 550.868 | 410.594 | 267.6 | 149.942 | 50.612 |
| Accumulated Other Comprehensive Income/Loss
| 0.917 | 262.74 | 235.705 | 188.317 | 150.524 | 125.06 | 114.202 | 85.931 | 60 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 1,090.611 | 1,090.936 | 1,066.518 | 1,013.141 | 677.976 | 941.844 | 1,030.495 | 1,030.495 | 1,150.495 | 144.551 | 134.473 | 99.551 | 105.106 |
| Total Shareholders Equity
| 3,436.015 | 3,373.901 | 3,244.735 | 2,804.427 | 2,674.097 | 2,554.113 | 2,318.173 | 2,096.569 | 1,881.363 | 645.144 | 492.073 | 358.284 | 245.717 |
| Total Equity
| 3,467.591 | 3,411.987 | 3,283.106 | 2,849.934 | 2,711.247 | 2,555.486 | 2,319.491 | 2,097.96 | 1,882.813 | 646.64 | 493.71 | 359.955 | 247.375 |
| Total Liabilities & Shareholders Equity
| 3,622.202 | 3,569.083 | 3,401.649 | 2,991.063 | 2,805.503 | 2,760.559 | 2,453.403 | 2,216.588 | 1,944.81 | 718.348 | 541.04 | 395.13 | 279.768 |